Document is current
Any future updates will be listed below
-
Authors
Nakanishi, Nobuhiro
Kaikita, Koichi
Oimatsu, Yu
Ishii, Masanobu
Kuyama, Naoto
Arima, Yuichiro
Araki, Satoshi
Nakamura, Taishi
Yamamoto, Eiichiro
Tsujita, Kenichi
-
Funding
Funding for this research was provided by:
SBI Pharmaceuticals Co., Ltd., Japan.
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 23 October 2024
First Online: 5 November 2024
Declarations
:
: Dr. Koichi Kaikita has received remuneration for lecturing from Bayer Yakuhin, Ltd., Daiichi-Sankyo Co., Ltd., Novartis Pharma AG., and Otsuka Pharmaceutical Co., Ltd.; has received trust research/joint research funds from SBI Pharmaceuticals Co., Ltd., Bayer Yakuhin, Ltd., and Daiichi-Sankyo Co., Ltd.; and has received scholarship funds from Abbott Medical Co., Ltd. Dr. Kenichi Tsujita has received remuneration for lecturing from Amgen Astellas BioPharma K.K., Bayer Yakuhin, Ltd., Bristol-Myers K.K., Daiichi Sankyo Co., Ltd., Kowa Pharmaceutical Co. Ltd., MSD K.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., ITI Co., Ltd., has received trust research/joint research funds from Bristol-Myers K.K., Kowa Pharmaceutical Co. Ltd., and has received scholarship funds from Abbott Medical Japan L.L.C, Abbott Vascular Japan Co., Ltd., Boston Scientific Japan K.K., Cardinal Health Japan, Chugai Pharmaceutical Co, Ltd., Fides-one, Inc., Fukuda Denshi Co., Ltd., Japan Lifeline Co., Ltd., Kaneka Medix Co., Ltd., Medtronic Japan Co., Ltd., Mitsubishi Tanabe Pharma, NIHON KOHDEN CORPORATION, NIPRO CORPORATION, Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and TERUMO Co, Ltd.Dr. Kenichi Tsujita is a member of Circulation Journal’s editorial team.
: The Animal Care and Use Committee of Kumamoto University (Reference number: A29-019) approved this study.
